C. Glader

Investigation of Cellular Interactions of Lipid-Structured Nanoparticles With Oral Mucosal Epithelial Cells

E. Fröhlich, E. Roblegg, A. Selmani, 2022, Frontiers in Molecular Biosciences.

Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden

G. Dahlén, H. Stenlund, L. S. Birgander, 2002, Journal of internal medicine.

Oestrogen receptor α gene polymorphism is related to aortic valve sclerosis in postmenopausal women

R. Lorentzon, P. Nordström, M. Lorentzon, 2003, Journal of internal medicine.

Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden.

L. Weinehall, G. Hallmans, B. Stegmayr, 1999, Stroke.

Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis.

P. Saikku, S. Söderberg, G. Dahlén, 2003, European heart journal.

The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies.

P. Saikku, L. Weinehall, G. Dahlén, 2000, European heart journal.